T1	outcome 1608 1623	Quality of life
T2	outcome 1569 1582	sleep outcome
T3	iv-bin-percent 1584 1587	40%
T4	cv-bin-percent 1591 1594	14%
T5	total-participants 1333 1335	53
T6	age 1348 1356	51 Â± 8 y
T7	intervention-participants 1399 1401	25
T9	control-participants 1432 1434	28
T10	total-participants 1437 1439	38
T11	intervention-participants 1464 1467	57%
T12	control-participants 1480 1483	88%
T14	eligibility 764 892	Women with breast cancer or at high risk for developing the disease who had hot flashes in association with nocturnal awakenings
T15	intervention 942 950	zolpidem
T8	control 960 967	placebo
T16	intervention 16 85	venlafaxine and selective serotonin reuptake inhibitors with zolpidem
T17	condition 95 120	sleep and quality of life
T18	outcome 1703 1714	hot flashes
T19	outcome 1719 1723	mood
